Lisata Therapeutics, Inc. SEC filings LSTA
Lisata Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form ARS, was filed on Oct 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Oct 19, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 19, 2026 | Nov 9, 2026 |
| 3 | Initial insider ownership | Oct 15, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 14, 2026 | Oct 13, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 7, 2026 | Nov 9, 2026 |
| D | Filing | Oct 2, 2026 | — |
| 3 | Initial insider ownership | Sep 28, 2026 | Sep 17, 2026 |
| 3 | Initial insider ownership | Sep 28, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 26, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Aug 4, 2026 | Aug 3, 2026 |
| SC TO-T/A | Filing | Jul 28, 2026 | — |
| 8-K |
Current report
Agreement ended, Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| SC 14D9/A | Filing | Jul 21, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 17, 2026 | Jul 16, 2026 |
| SC 14D9/A | Filing | Jul 17, 2026 | — |
| SC TO-T/A | Filing | Jul 17, 2026 | — |
| SC 14D9/A | Filing | Jul 13, 2026 | — |
| SC TO-T/A | Schedule to-t/a | Jul 10, 2026 | — |
| SC 14D9/A | Filing | Jul 2, 2026 | — |
| SC 14D9 | Filing | Jun 10, 2026 | — |
| SC TO-T | Filing | Jun 10, 2026 | — |
| SC14D9C | Filing | Jun 9, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jun 9, 2026 | Jun 8, 2026 |
| SC TO-C | Filing | Jun 1, 2026 | — |
| SC14D9C | Filing | Jun 1, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| SC TO-C | Filing | May 29, 2026 | — |
| SC14D9C | Filing | May 29, 2026 | — |
| 8-K |
Current report
Material agreement
|
May 29, 2026 | May 29, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| SC TO-C | Filing | May 4, 2026 | — |
| SC14D9C | Filing | May 4, 2026 | — |
| 8-K |
Current report
Material agreement
|
May 4, 2026 | May 3, 2026 |
| 10-K/A | Amended annual report | Apr 28, 2026 | Dec 31, 2025 |
| SC14D9C | Filing | Apr 15, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 15, 2026 | Apr 15, 2026 |
| SC14D9C | Filing | Apr 3, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 3, 2026 | Apr 2, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| SC14D9C | Filing | Mar 9, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 9, 2026 | Mar 6, 2026 |
| SC14D9C | Filing | Feb 27, 2026 | — |
| 8-K |
Current report
Material agreement
|
Feb 27, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| SC14D9C | Sc 14d9c | Jan 21, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jan 21, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| S-8 | Employee stock plan registration | Jan 8, 2026 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 14, 2025 |
| 8-K |
Current report
Material agreement
|
Oct 8, 2025 | Oct 8, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2025 | Jun 10, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 3 | Initial insider ownership | Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 4 | Insider transaction | Jan 13, 2025 | Jan 9, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 3, 2024 | Dec 3, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 12, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Oct 1, 2024 |
| 424B5 | Prospectus supplement | Aug 21, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2024 | Aug 12, 2024 |
| S-8 | Employee stock plan registration | Jul 15, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jun 27, 2024 | Jun 27, 2024 |
| EFFECT | Filing | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2024 | May 9, 2024 |
| CORRESP | Letter to the SEC | May 7, 2024 | — |
| UPLOAD | Letter from the SEC | May 6, 2024 | — |
| S-3 | Shelf registration | May 1, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| 3 | Initial insider ownership | Apr 24, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2024 | Apr 15, 2024 |
| ARS | Annual report to shareholders | Mar 28, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 11, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 4 | Insider transaction | Jan 11, 2024 | Jan 9, 2024 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 4 | Insider transaction | Sep 5, 2023 | Sep 1, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2023 | Aug 14, 2023 |
| S-8 | Employee stock plan registration | Jul 13, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | May 1, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 4 | Insider transaction | Jan 17, 2023 | Jan 13, 2023 |
| 4 | Insider transaction | Jan 12, 2023 | Jan 11, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 4 | Insider transaction | Jan 11, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| S-8 | Employee stock plan registration | Oct 17, 2022 | — |
| 8-K/A | Amended current report | Oct 14, 2022 | Sep 14, 2022 |
| 8-K/A |
Amended current report
Other events
|
Oct 4, 2022 | Sep 14, 2022 |
| 8-K |
Current report
Other events
|
Sep 29, 2022 | Sep 29, 2022 |
| 424B5 | Prospectus supplement | Sep 26, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2022 | Sep 22, 2022 |
| 3 | Initial insider ownership | Sep 16, 2022 | Sep 15, 2022 |
| 3 | Initial insider ownership | Sep 16, 2022 | Sep 15, 2022 |
| 3 | Initial insider ownership | Sep 16, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 16, 2022 | Sep 15, 2022 |
| 3 | Initial insider ownership | Sep 16, 2022 | Sep 15, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 15, 2022 | Sep 14, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
|
Sep 14, 2022 | Sep 13, 2022 |
| 4 | Insider transaction | Sep 2, 2022 | Sep 1, 2022 |
| 4 | Insider transaction | Sep 2, 2022 | Sep 1, 2022 |
| 425 | Filing | Sep 2, 2022 | — |
| 8-K |
Current report
Listing notice
|
Aug 19, 2022 | Aug 18, 2022 |
| 425 | Filing | Aug 15, 2022 | — |
| 425 | Filing | Aug 10, 2022 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2022 | Aug 4, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 424B3 | Prospectus | Jul 29, 2022 | — |
| EFFECT | Filing | Jul 28, 2022 | — |
| CORRESP | Letter to the SEC | Jul 26, 2022 | — |
| S-4/A | Filing | Jul 26, 2022 | — |
| 425 | Filing | Jul 6, 2022 | — |
| S-4 | Registration for a merger or exchange | Jun 15, 2022 | — |
| 425 | Filing | Jun 9, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2022 | May 23, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 5, 2022 | May 5, 2022 |
| 425 | Filing | Apr 27, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Apr 27, 2022 | Apr 26, 2022 |
| 10-K/A | Amended annual report | Apr 21, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 22, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Listing notice
|
Feb 18, 2022 | Feb 18, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 19, 2022 | — |
| 4 | Insider transaction | Jan 18, 2022 | Jan 13, 2022 |
| 4 | Insider transaction | Jan 18, 2022 | Jan 13, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
| 4 | Insider transaction | Jan 12, 2022 | Jan 10, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LSTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Basking Ridge, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 320017
- Former names
- Caladrius Biosciences, Inc. (until Sep 15, 2022); CALADRIUS BIOSCIENCES, INC. (until Sep 15, 2022); NeoStem, Inc. (until Jun 5, 2015); PHASE III MEDICAL INC/DE (until Sep 1, 2006); CORNICHE GROUP INC /DE (until Aug 14, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.